Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Last year, the British pharmaceuticals producer GlaxoSmithKline took over the vaccine division of Novartis. As a consequence, the enterprise is now confronted with a lot of overlap and double filled functions. The Research and Development department in Belgium is contracting by some 340 posts, the majority of them senior and skilled. Half will move to another job in GSK. The remaining 170 will leave the company.
The trade union is negotiating for priority to be given to voluntary departure and voluntary switches to part-time jobs. They indicate that social partner negotiations are taking place in an open and positive atmosphere. GSK employs 8,900 people in Belgium.
Eurofound (2015), GlaxoSmithKline, Merger/Acquisition in Belgium, factsheet number 85650, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/85650.